12.20EUR-2.56%Mkt Cap: 385.77M $P/E: 20.681d ago
Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company of…
Indicators:|
Key Statistics
Company
Market Cap385.77M $
Enterprise Value348.83M $
Revenue (TTM)120.70M $
Gross Profit84.57M $
Net Income (TTM)18.93M $
Revenue/Share4.520 USD
Last Price12.20 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees246
CountryFI
SectorHealthcare
IndustryMedical Devices
ISINFI0009010912
Valuation
P/E (Trailing)20.68
P/E (Forward)12.56
PEG6.37
EV/EBITDA13.37
EV/Revenue2.89
P/S3.20
P/B2.83
EPS (TTM)0.59
EPS (Forward)0.97
52W Range
12.081% of range29.10
52W High29.10 EUR
52W Low12.08 EUR
Profitability
Gross Margin70.94%
Oper. Margin8.43%
EBITDA Margin21.61%
Profit Margin15.88%
ROE15.18%
ROA11.56%
Growth
Revenue Growth4.60%
Earnings Growth-41.40%
Cash Flow & Leverage
Operating CF32.86M $
CapEx (TTM)4.54M $
FCF Margin12.47%
FCF Yield3.90%
Net Debt-11.52M $
Net Debt/EBITDA-0.44
Balance Sheet
Debt/Equity0.10
Current Ratio2.27
Quick Ratio1.76
Book Value/Sh4.317 EUR
Cash/Share0.7880 EUR
Dividends
Fwd Div Rate0.4000 EUR
Trail. Div Rate0.4400 EUR
Div. Yield2.04%
5Y Avg Yield1.21%
Payout Ratio67.85%
Ex-Div DateApr 11, 2025
Pay Date—
Splits
Last Split2:1
Split DateMar 20, 2020
Analyst Consensus
Rating—
Target (Mean)19.38 EUR
Upside (mean)+58.8%
Target Range15.00 EUR – 23.50 EUR
€15.00+58.8% to mean€23.50
# Analysts4
Ownership
Shares Out.29.09M
Float25.16M
Insiders10.62%
Institutions53.88%
Technical
SMA 5013.75 (-11.3%)
SMA 20019.40 (-37.1%)
Beta0.84
S&P 52W Chg20.05%
Avg Vol (30d)51.48K
Avg Vol (10d)45.67K
Technical Indicators
RSI (14)31.2
MACD-0.4585
MACD Signal-0.5130
MACD Hist.+0.0545
BB Upper13.57 EUR
BB Middle12.81 EUR
BB Lower12.06 EUR
BB Width11.83%
ATR (14)0.4253 EUR
Vol Ratio (20d)0.92x